Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant

Abstract

Aim: The purpose of this study is to assess the benefit of laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) given recurrence and future need for liver transplantation (LT).

Methods: Data on liver resections were gathered from the Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione (IRCCS-ISMETT) from 2003-2021. A retrospective analysis of 1408 consecutive adult patients who had a liver resection was performed with categorization based on the underlying disease process. A sub-analysis studied the 291 patients who had an LLR with an intention to transplant approach after LLR.

Results: From 2012 to 2020, ISMETT’s mean annual LLR rate was 45%. Data suggests that a laparoscopic approach to iterative surgical treatment for HCC has demonstrated protective benefits. Compared to open surgery or LT, LLR is protective against the risk of de-listing, post-transplant patient death, tumor recurrence, adhesions, and bleeding in a cirrhotic patient. Kaplan Meier’s analysis showed no difference between post-LT survival curves for those with prior open abdominal surgery or LLR (P = 0.658).

Conclusion: Laparoscopic surgery has important protective advantages over laparotomy surgery for the surgical treatment of HCC, particularly since treatment is not always curative. LLR can be considered a bridge therapy for transplantation, ensuring less crowding of waiting lists, a desirable condition in areas of donor storage.

Keywords

Laparoscopic / liver resection / hepatocellular carcinoma / minimally invasive liver surgery

References

[1] Yang JD.Epidemiology and management of hepatocellular carcinoma.Infect Dis Clin North Am2010;24:899-919, viii PMCID:PMC3949429

[2] Llovet JM,Villanueva A.Hepatocellular carcinoma.Nat Rev Dis Primers2021;7:6

[3] Cillo U,Polacco M.Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.Hepatology2017;65:1741-8

[4] Khouzam S,Barbàra M.Impact of Italian score for organ allocation system on deceased donor liver transplantation: a monocentric competing risk time-to-event analysis.Transplant Proc2019;51:2860-4

[5] Shimamura T,Watanabe M,Takada Y.Liver transplantation for hepatocellular carcinoma: how should we improve the thresholds?.Cancers (Basel)2022;14:419 PMCID:PMC8773688

[6] Gruttadauria S,Vizzini GB.Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes.World J Gastroenterol2009;15:4556-60 PMCID:PMC2752000

[7] Vogel A,Chau I.ESMO Guidelines CommitteeHepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol2018;29:iv238-55

[8] Vogel A,Chau I.Correction to: “hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”.Ann Oncol2019;30:871-3

[9] Gruttadauria S,Corsini LR.Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis.Updates Surg2020;72:109-17

[10] Kudo M,Ye SL.A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements.Liver Cancer2020;9:245-60 PMCID:PMC7325125

[11] Sato T,Ebara M.Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study.Hepatol Int2015;9:330-6 PMCID:PMC4387310

[12] Coelho FF,Fonseca GM.Laparoscopic liver resection: experience based guidelines.World J Gastrointest Surg2016;8:5-26 PMCID:PMC4724587

[13] Tranchart H,Lainas P.Laparoscopic resection for hepatocellular carcinoma: a matched-pair comparative study.Surg Endosc2010;24:1170-6

[14] Lee KF,Wong J,Wong J.Long-term results of laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma: a case-matched analysis.World J Surg2011;35:2268-74

[15] van Dam RM,van Breukelen GJ.ORANGE II Study GroupOpen versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS^® programme (ORANGE II-trial): study protocol for a randomised controlled trial.Trials2012;13:54 PMCID:PMC3409025

[16] Le Roux F,Cosse C.Benefits of laparoscopic approach for resection of liver tumors in cirrhotic patients.J Laparoendosc Adv Surg Tech A2018;28:553-61

[17] Allaire M,Lim C,Wagner M.New frontiers in liver resection for hepatocellular carcinoma.JHEP Rep2020;2:100134 PMCID:PMC7360891

[18] Troisi RI,Morise Z.Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.Br J Surg2021;108:196-204

[19] Krenzien F,Haber P.Validity of the Iwate criteria for patients with hepatocellular carcinoma undergoing minimally invasive liver resection.J Hepatobiliary Pancreat Sci2018;25:403-11

[20] Ortiz Galindo SA,Benzing C.Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosis.Langenbecks Arch Surg2022;407:235-44 PMCID:PMC8847278

[21] Vega EA,Joechle K,Ko D.Preoperative prognosticators of safe laparoscopic hepatocellular carcinoma resection in advanced cirrhosis: a propensity score matching population-based analysis of 1799 western patients.J Gastrointest Surg2019;23:1157-65

[22] Yu W,Wang L,Xu Q.R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma.World J Surg2014;38:1777-85

[23] Gruttadauria S,Liotta R.Liver volume restoration and hepatic microarchitecture in small-for-size syndrome.Ann Transplant2015;20:381-9

[24] Scilletta R,Spada M.Comparative analysis of the incidence of surgical site infections in patients with liver resection for colorectal hepatic metastases after neoadjuvant chemotherapy.J Surg Res2014;188:183-9

[25] Gruttadauria S,Pagano D.Impact of blood transfusion on early outcome of liver resection for colorectal hepatic metastases.J Surg Oncol2011;103:140-7

[26] Gruttadauria S,Luca A.Small-for-size syndrome in adult-to-adult living-related liver transplantation.World J Gastroenterol2010;16:5011-5 PMCID:PMC2965275

[27] Gruttadauria S,Pagano D.Early regeneration of the remnant liver volume after right hepatectomy for living donation: a multiple regression analysis.Liver Transpl2012;18:907-13

[28] Enomoto S,Shingaki N.Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.Hepatol Int2011;5:730-7 PMCID:PMC3090556

[29] Kim SS,Kim MJ.Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.Eur Radiol2021;31:3405-16

[30] Gruttadauria S,Conaldi PG.Clinical and molecular-based approach in the evaluation of hepatocellular carcinoma recurrence after radical liver resection.Cancers (Basel)2021;13:518 PMCID:PMC7866287

[31] Bae JJ,Lee TJ.Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.Oncol Rep2007;18:1007-13

[32] Fujiwara Y,Yamada T.PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.Jpn J Cancer Res2000;91:287-92

[33] Levi Sandri GB,Ravaioli M.The role of salvage transplantation in patients initially treated with open versus minimally invasive liver surgery: an intention-to-treat analysis.Liver Transpl2020;26:878-87

[34] Aldrighetti L,Cillo U.Italian Group of Minimally Invasive Liver Surgery (I GO MILS)Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.Updates Surg2017;69:271-83

[35] Gruttadauria S,Pagano D.Mini-invasive approach contributes to expand the indication for liver resection for hepatocellular carcinoma without increasing the incidence of posthepatectomy liver failure and other perioperative complications: a single-center analysis.J Laparoendosc Adv Surg Tech A2016;26:439-46

[36] Levi Sandri GB,Aldrighetti L.I Go MILS Group on HCCIs minimally invasive liver surgery a reasonable option in recurrent HCC?.Updates Surg2022;74:87-96